Small-Cap Momentum Watch: Upcoming Catalysts for November 23–27

11/22/20267 min read

From operational updates to conference participation, we’ve highlighted the small-cap events that could drive attention this week.

--

Companies with Material Events This Week

DRIO – CEO Erez Raphael will lead a virtual panel at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum on November 23 from noon to 12:50 p.m. ET. He’ll join Personify Health President Ed Liebowitz to discuss digital care for multiple chronic conditions, member engagement, and measurable returns for payers.

NTHI – Will meet with the FDA on November 23 for its rescheduled End-of-Phase 1 Type B meeting on oral NEO212. NeOnc will seek feedback on its proposed Phase 2 patient populations, trial design, endpoints, dose selection, and potential regulatory pathways.

ELBM – CFO Peter Rawlins will meet with investors at the 121 Mining Investment Conference in London on November 23–24 to discuss construction and commissioning readiness at Electra’s cobalt refinery. Management will also join a November 24 panel at the Ontario Critical Minerals Forum in Toronto on building Canadian processing and refining capacity.

HYPR – Management will hold virtual investor meetings at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum on November 23.

ALVO – Management will hold fireside chats at the DNB Carnegie Healthcare Conference in Oslo on November 24 at 7:20 a.m. ET and the SEB Healthcare Seminar in Stockholm on November 25 at 4:40 a.m. ET.

SEGG – Plans to relaunch its TicketStub platform on November 25 with a Black Friday offer. SEGG Media also plans to release ticket discount codes throughout the holiday season.

RZAI – CEO Young Jin Cho and the Roze AI team will ring the Nasdaq opening bell on November 25 at 9:30 a.m. ET at Nasdaq MarketSite, marking the company’s September 29 listing.

CXAI – Subsidiary EngineRoom will showcase its AI powered growth intelligence platform at The Business Show Australia on November 25–26 at ICC Sydney, stand B1236. The showcase follows EngineRoom’s technology partnership with field service software provider Simpro Group.

HIHO – November 27 is the record date for Highway Holdings’ special cash dividend of $0.43228 per common share, payable November 30. The $2 million distribution is part of the company’s strategic investment transaction with David Lazar.

NUS – November 27 is the record date for Nu Skin’s quarterly cash dividend of $0.06 per share, payable December 9.

PYPD – The FDA’s Priority Review goal date for D PLEX₁₀₀ is Saturday, November 28. PolyPid is seeking approval to prevent surgical site infections in patients undergoing colorectal surgery and has reported that labeling discussions are underway.

NNOX – Will showcase its FDA-cleared Nanox.ARC X imaging system and Nanox.AI tools at RSNA 2026 in Chicago, with technical exhibits opening Sunday, November 29. Nanox will also preview imaging and AI features still in development at Booth 1759.

INTJ – Expects to close its RMB46.14 million cash acquisition of a 51% stake in Thailand’s Dingli & SF Solar Energy on or around November 26. Intelligent Group’s board and audit committee approved the related-party transaction.

FNGR – Sunday, November 29, 2026, is the estimated end of the 60-day due-diligence period for FingerMotion and BlueFlare’s proposed purchase of the 20.2-acre Hanna Campus #1 site in Alberta. Financing, zoning, and permitting are among the conditions. The agreement schedules closing 30 days after the applicable conditions are waived, putting it around December 29 if the waiver occurs on November 29.

Shareholder Votes, Corporate Actions & Key Deadlines

ONFO – November 23 was the deadline Nasdaq originally gave Onfolio to regain compliance with its $2.5 million minimum stockholders’ equity requirement. Onfolio reported $2.90 million as of September 30 and is awaiting Nasdaq’s confirmation. The company has requested a hearing to appeal Nasdaq’s delisting determination, which also cited the $1 minimum bid price requirement. Nasdaq’s notice sets a November 24 market-open suspension if the hearing request and fee confirmation were late, while Onfolio says its shares will continue trading during the appeal.

NCEL – Expects to close its $1.55 million private placement on or about November 23, subject to customary closing conditions. The deal includes 471,125 common shares at $3.29 per share, a 20% premium to the November 6 close, and five-year warrants for up to 353,344 shares at $3.75. NewcelX plans to use the proceeds primarily to advance NCEL-101 and prepare for a Phase 1/2a type 1 diabetes trial in 2027.

OPTT – Will hold a virtual special meeting on November 24 at 9:00 a.m. ET. Shareholders will vote on allowing share issuances above the 19.99% exchange cap in connection with $7.80 million in Series D convertible notes and authorizing a reverse split of up to 1-for-6.6 within one year. The notes carry a $2.45 conversion price or an alternative price equal to 93% of the lowest VWAP over the seven trading days before conversion.

UPXI – Will hold a special meeting in Tampa on November 24 at 9:00 a.m. ET. Shareholders will vote on common-stock issuances tied to the July 2025 and January 2026 secured convertible notes and on authorizing one or more reverse splits at ratios of 1 for-2 to 1-for-4 within one year.

IMTE – Will hold an extraordinary general meeting in Adelaide on November 25 at 12:30 p.m. local time, equivalent to November 24 at 9:00 p.m. ET. Shareholders will vote on authorizing a 1-for-2 to 1 for-10 reverse split, with the board to set the ratio and effective date. The company’s deadline to regain compliance with Nasdaq’s $1 minimum bid-price requirement is December 29.

DCX – Will hold a virtual extraordinary general meeting on November 25 at 10:00 a.m. Hong Kong time, equivalent to November 24 at 9:00 p.m. ET. Shareholders will vote on a 1-for-5 reverse split of Class A and Class B ordinary shares, related charter amendments, and a conditional change of domicile from the Cayman Islands to the British Virgin Islands.

NNOX – Will hold its rescheduled special general meeting in Petach Tikva, Israel, on November 25 at 7:00 a.m. ET. Shareholders will vote on increasing authorized ordinary shares from 150 million to 350 million, authorizing a 1-for-20 to 1-for-50 reverse split within 18 months, and generally requiring a two-thirds board vote to remove or replace the chair. Proxies are due November 24 at 11:59 p.m. ET.

BOXL – Plans to request a Nasdaq hearing by November 25 to appeal a delisting determination after reporting about $1.9 million in stockholders’ equity against the $2.5 million minimum. A timely request would stay any trading suspension pending the panel’s decision. The SEC has declared effective the resale registration covering shares tied to its Series D preferred financing and up to $15 million equity line.

WHLR – November 25 is the deadline to submit Series D preferred-stock redemption requests for the December 7 holder redemption date. The previous round lowered the conversion price of Wheeler’s 7% subordinated convertible notes to approximately $0.59 per common share. The next round could trigger another adjustment.

CTW – Will hold its annual general meeting in Tokyo on November 27 at 10:00 a.m. local time, equivalent to November 26 at 8:00 p.m. ET. Shareholders will vote on authorizing a reverse split of Class A ordinary shares of up to 1-for-300, with the board able to set the ratio and timing within three years.

VRAX – Will hold an extraordinary general meeting at BioCity Glasgow on November 27 at 9:00 a.m. ET. Shareholders will vote on a 1-for-4 reverse split targeted for December 14 or a later date accepted by Nasdaq, and a conditional increase in authorized ordinary shares from 125 million after the split to 500 million.

SMX – Will hold its annual general meeting in Dublin on November 27 at 9:00 a.m. ET. Shareholders will vote on a capital reduction to create distributable reserves for potential dividends, share redemptions, or repurchases. The proposal requires at least 75% of votes cast and confirmation by the Irish High Court.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.

Disclaimer: Penny stock trading involves substantial risk, so always research every alert before trading, consult with a licensed professional before trading, only invest what you can afford to lose, and always trade with caution. Readers should independently investigate and fully understand all risks before investing. Results listed are NOT typical and individual results may and most likely will vary. Bigtimepennystocks.com and its staff are NOT licensed investment advisors or broker/dealers of any kind.Alerts are not a solicitation or recommendation to buy/sell/hold securities but merely investment ideas that should NEVER serve as the basis of your trading decisions. Bigtimepennystocks.com and its newsletter are for entertainment purposes only. This website and its reports are for general information purposes as we are engaged in the business of marketing and advertising companies for monetary compensation. Any investment decision should be discussed with a financial adviser before taking place. Please invest carefully and read investment information available at the website of the SEC at http://www.sec.gov.

Subscribe to our Free Newsletter

Copyright © 2023 BigTimePennyStocks.com - All Rights Reserved.